BOSTON—-BioSTAR , a device that incorporates a bioresorbable collagen scaffold used to treat patent foramen ovale has received regulatory approval in Canada and Europe. PFO is a common defect between the right and left atrium of the heart; essentially a hole in the heart that is usually asymptomatic.
More: continued here